Morgan Stanley
BIOA

Morgan Stanley’s BioAmber Inc. BIOA Stock Holding History

Morgan Stanley’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,572
Closed -$5K – 6865
2017
Q4 		$5K Sell
11,572
-109,125
-90% -$51.9K ﹤0.01% 6352
2017
Q3 		$60K Buy
120,697
+107,595
+821% +$128K ﹤0.01% 5731
2017
Q2 		$34K Sell
13,102
-50
-0.4% -$115 ﹤0.01% 5962
2017
Q1 		$31K Sell
13,152
-400
-3% -$1.52K ﹤0.01% 5966
2016
Q4 		$75K Buy
13,552
+250
+2% +$1.2K ﹤0.01% 5657
2016
Q3 		$56K Buy
13,302
+1,050
+9% +$3.88K ﹤0.01% 5543
2016
Q2 		$36K Sell
12,252
-875
-7% -$3.19K ﹤0.01% 5646
2016
Q1 		$55K Sell
13,127
-300
-2% -$1.26K ﹤0.01% 5583
2015
Q4 		$83K Sell
13,427
-945
-7% -$7.12K ﹤0.01% 5509
2015
Q3 		$78K Hold
14,372
– – ﹤0.01% 5545
2015
Q2 		$124K Buy
14,372
+2,900
+25% +$26.5K ﹤0.01% 5478
2015
Q1 		$100K Buy
11,472
+1,400
+14% +$12.3K ﹤0.01% 5529
2014
Q4 		$85K Buy
10,072
+100
+1% +$910 ﹤0.01% 5617
2014
Q3 		$100K Buy
9,972
+1,400
+16% +$16.4K ﹤0.01% 5484
2014
Q2 		$85K Sell
8,572
-2,442
-22% -$25.2K ﹤0.01% 5567
2014
Q1 		$126K Buy
11,014
+6,014
+120% +$71.2K ﹤0.01% 5345
2013
Q4 		$37K Buy
+5,000
New +$34.2K ﹤0.01% 5708

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Morgan Stanley's BIOA Position: Q1 2018 in Review

Morgan Stanley sold out of BioAmber Inc. (BIOA) in Q1 2018, closing a stake of 11,572 shares — an estimated $5K sold.

Morgan Stanley first reported a position in BIOA in Q4 2013 and held it in 17 quarters. The position peaked at $126K in Q1 2014. 4 funds tracked by Wall St. Rank hold BIOA as of Q1 2018.

  • Morgan Stanley reported no remaining BioAmber Inc. position as of Q1 2018 after selling out during the quarter.
  • Morgan Stanley sold 11,572 BioAmber Inc. shares in Q1 2018, an estimated $5K.
  • Morgan Stanley first reported a position in BioAmber Inc. in Q4 2013 and held it in 17 quarters.
  • Morgan Stanley's BioAmber Inc. position peaked at $126K in Q1 2014.
  • 4 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2018.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.